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Abstract 
In this present study, a fully integrated BioMEMS was developed using silicon technology to simultaneously detect varying 
cytokine biomarkers: interleukin-1 (IL-1), interleukin-10 (IL-10), and interleukin-6 (IL-6) using eight gold working 
microelectrodes (WE). The biomarkers are one of many antigens that are secreted in acute stages of inflammation after left 
ventricle assisted device (LVAD) implantation for patients suffering from heart failure (HF). The monoclonal antibodies (mAb): 
anti-human IL-1, IL-10, and IL-6 were immobilized onto gold microelectrodes through functionalization with carboxyl 
diazonium, respectively. Cyclic voltammetry (CV) was applied during the microelectrode functionalization process to 
characterize the gold microelectrode surface properties, while electrochemical impedance spectroscopy (EIS) was used to 
characterize the modified gold microelectrodes. The BioMEMS was highly sensitive towards the three cytokines in a range of 1 
pg/mL to 15 pg/mL, which is the window where acute inflammations were observed. 
 
© 2014 The Authors. Published by Elsevier Ltd. 
Peer-review under responsibility of the scientific committee of Eurosensors 2014. 
Keywords: BioMEMS; heart failure; impedance spectroscopy; cytokine biomarkers; microtechnology 
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
Peer-review under responsibility of the scientific committee of Eurosensors 2014
378   A. Baraket et al. /  Procedia Engineering  87 ( 2014 )  377 – 379 
1. Introduction 
Heart failure (HF) is a cardiovascular disease (CVD) which is amongst the most increasing causes of death in 
western countries [1]. HF is a condition where the heart is unable to perform its normal functionality of circulating 
blood through the lungs and back out to the tissues. However, facing the difficulty of obtaining a sufficient number 
of donor organs, several bioelectronic devices such as pressure sensors and left ventricle assisted device (LVADs) 
have been implanted into the patients’ body in order to monitor or facilitate the continuation of the patients’ life 
until such a donor becomes available. The problem of organ biocompatibility as a direct cause to implanted LVADs 
can trigger increased pro- and anti-inflammatory cytokine levels, which is amongst the principle origins of HF. For 
this interest, and in order to detect minute concentrations of these secreted biomarkers, several device-based 
therapeutic approaches roused the interest of the scientific researchers in this field. A new point-of-care biological 
sensor capable of sensitive and specific detection of biomolecules [2,3] has observed an interesting growth in order 
to evaluate the first signs of inflammation and/or sepsis markers using biosensors for HF monitoring in patients with 
LVADs. We report in the present work, the fabrication of a BioMEMS based on silicon substrate for multiple 
cytokine detection. This BioMEMS contains eight gold working electrodes (WE) which allow the simultaneous 
detection of different cytokines through electrically addressable diazonium-functionalized antibodies (Ab). 
2. Experimental and results  
Cyclic voltammetric and the electrochemical impedance spectra (EIS) were conducted with a multichannel 
potentiostat (Biologic-EC-Lab VMP3). All experiments were measured at room temperature. The modeling of the 
obtained EIS data was made by the EC-Lab software using the Randomize + Simplex method, with randomize 
stopped on 100,000 iterations and the fit stopped on 5,000 iterations. 
 
Fig. 1: Final chip fabricated on silicon substrate which contains eight WE, CE and RE. 
 
The fabricated silicon chip incorporates an array of eight gold microelectrodes which can work as a WEs. It also 
incorporates a reference microelectrode (RE) based on Ag/AgCl and a counter microelectrode (CE) based on 
platinum (Fig. 1). Carboxyl diazonium was electro-addressed to the different gold WE by applying CV (3 cycles) 
from 0.3 V to -1.4 V with a scan rate of 200 mV/s in a solution of ferricyanide (5mM) and potassium chloride (KCl) 
(0.1M) at pH 7.4 for the immobilization of anti-IL-10, IL-6 and IL-1, respectively. Afterwards, the mAbs were 
covalently immobilized to the functionalized diazonium through N-hydroxysuccinimide (NHS) and N-(3-
dimethylaminopropyl)-N’-ethyl-carbodiimide hydrochloride (EDC) cross-linking with both concentrations made to 
0.1 M [4].  
 
The EIS measurement was further used to monitor the interaction between cytokine biomarkers and the 
corresponding antibodies, in redox probe solution K3(Fe(CN)6)/K4(Fe(CN)6) (5 mM) in PBS buffer at pH 7.4 with 
increasing concentrations of biomarkers. The applied frequency was made from 100 mHz to 100 kHz, using a 
modulation voltage of 25 mV, and a fixed potential at -0.2 V.  
 
In order to evaluate the recognition properties of the system, in terms of sensitivity and selectivity, we exposed the 
BioMEMS to various concentrations of human IL-10. The diameter of the semi-circle on the corresponding Nyquist 
plots increased (Fig. 2(aI)), because the antigens in solution were captured by the antibodies immobilized on the 
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gold microelectrode surface, which in turn, blocked the charge transfer between the working microelectrode and the 
redox probe, Fe(CN)63-/4- pair, resulting in an increased charge transfer resistance, Rct. The total charge transfer 
resistances obtained in the presence of antigens of various concentrations (Rct, Ab+Ag) were normalized with respect to 
that obtained only with its antibodies (Rct,Ab) and presented by dividing the Rct, Ab+Ag, s by Rct,Ab. As can be seen in 
Fig. 2(aII), a linear dependence of Rct, Ab+Ag/Rct,Ab on the antigen concentration was observed. The detection limit 
estimated from the calibration line is about 1pg/mL.  
 
To confirm that the above-observed impedance changes arise from the specific interaction between human IL-10 
and anti-IL-10, and to reveal the selectivity of the binding, control experiments were performed by adding other 
antigens (IL-1, IL-6). Fig. 2(aII) shows calibration plots corresponding to the normalized resistance change with 
different concentrations of the specific analyte (IL-10) and non-specific analyte (IL-6, IL-1). From this figure it can 
be observed that there is no or a slight response to unrelated analyte addition. We thus confirm that impedance 
change is not due to non-specific adsorption but arises from specific interaction. The same results were obtained for 
both IL-6 and IL-1.  
 
Fig. 2. (aI) Nyquist plot demonstrating detection of varying IL-10 concentrations in comparison with the IL-10 Ab. (aII) Normalized curve by 
EIS detection of the logarithm of (black) IL-10 and selectivity of (red) IL-1 and (blue) IL-6 with concentrations ranging from 1 pg/mL to 15 
pg/mL against the variation of the Rp calculated by 'R/R.  
3. Conclusions 
In the present work, we have shown the feasibility of manufacturing a BioMEMS that is sensitive and capable of 
multiple simultaneous detections of cytokine biomarkers. The immobilization of mAb by electro-addressing opens 
the possibility to detect different cytokines at the same time. Good sensitivity and reproducibility were obtained for 
IL-10, IL-6 and IL-1. The developed BioMEMS will be used in the future as a chip for a small wearable potentiostat 
in order to detect several biomarkers secreted after LVAD implantation.  
Acknowledgements  
This work was funded by the European Communities Seventh Framework Programme (FP7/2007-2013) under the 
grant agreement No. 248763 (SensorART) and FP7-PEOPLE-2012-IRSES under the grant agreement No. 318053 
(SMARTCANCERSENS) and SPS (NUKP.SFPP984173) NATO project. 
References 
[1] Costanzo M.R., et al, J. Heart Lung Transplant. 29 (2010) 914-56. 
[2] Ainslie K. M., Desai T. A., Lab Chip, 8 (2008) 1864. 
[3] Baraket A., Lee M., Zine N., Besseuille F., Yaakoubi N., Trivella M.G., Bausells J., Zabala M., Jaffrezic-Renault N., Errachid A., IJAO, 
2011, 34, 661-662. 
[4] Baraket A., Lee M., Zine N., Sigaud M., Yaakoubi N., Trivella M.G., Bausells J., Zabala M., Jaffrezic-Renault N., Errachid A., Sens.  
     Actuators B 189(2013) 165–172 
